awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38194112-23573A1B-66DC-4964-AAF5-9C5439A41A31
Q38194112-23573A1B-66DC-4964-AAF5-9C5439A41A31
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38194112-23573A1B-66DC-4964-AAF5-9C5439A41A31
The efficacy and tolerability of commonly used agents to prevent recurrence of atrial fibrillation after successful cardioversion.
P2860
Q38194112-23573A1B-66DC-4964-AAF5-9C5439A41A31
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38194112-23573A1B-66DC-4964-AAF5-9C5439A41A31
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2f590fb4f662007e1be8258aa78e61078e718cc5
P2860
VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study).